Intel Corp. (NASDAQ:INTC) is advancing its semiconductor manufacturing strategy through its 18A process, expanding its foundry operations, and developing new AI-focused and high-performance processors. The company is also investing in advanced packaging and manufacturing capacity. These developments aim to strengthen Intel’s competitiveness, attract external foundry customers, and support long-term growth.
Read Intel (INTC) Can Fill Only Half its CPU Orders. Is That a Problem or a Signal? to uncover supply chain bottlenecks for Intel.
Photo by Slejven Djurakovic on Unsplash
Is Altera Stake a Hidden Catalyst
Intel’s 49% existing stake in chipmaker, Altera, offers interesting prospects to shareholders. Altera is on course to return to the public markets after 11 years, as its parent company has confidentially submitted a draft registration statement for a proposed IPO. It was acquired by Intel for $16.7 billion in 2015, before Silver Lake bought a controlling stake of 51% in 2025. Going public could unlock valuation for Altera, which Intel would be looking forward to, as the company plans on a large-scale spending to expand its foundry business through major technological milestones like the 18A and 14A nodes.
Conventional server CPUs present another compelling opportunity to Intel, as it pushes to restore its competitive edge across the space. At the same time, demand for CPUs used in AI inference and agentic AI workloads has been driving much of the market sentiment around the stock. However, such deployments require significant amount of specialized computing capabilities, API integrations, strong memory services, and multi-user coordination.
What Could Go Wrong
Shortages of memory, substrates, and other critical components, along with Intel’s internal factory capacity constraints, add to the company’s supply chain hurdles. The company is currently in a position to meet about half of current customer demand for processors. This could result in user churn and loss of market share as time-constrained customers would look for other options for supplies.
Intel’s involvement in the massive “Terafab” semiconductor initiative, involving SpaceX and Tesla, does offer long-term potential around AI compute capacity expansion. However, the financial terms of Intel’s involvement and its potential revenue contribution have not been disclosed, leaving uncertainty around the near-term financial impact of the collaboration.
Institutional Sentiment
Based on data tracked across 1,000+ hedge funds by Insider Monkey, institutional sentiment toward the company remains encouraging. According to 13F filing data, number of smart-money managers in the stock has been going up. A total of 138 hedge funds held positions by the end of Q2 2026, compared to 112 in Q1 2026. Short interest is hovering slightly below 3%, which shows that investors are not carrying out too many speculative bets against the stock.
BlackRock is the largest institutional stakeholder, as per Yahoo Finance database, holding 426.48 million shares as of June 30. This amounts to 8.46% of outstanding shares. Other notable institutional investors include Vanguard Capital Management and State Street Corporation, holding 5.65% and 4.30% of outstanding shares respectively.
Verdict
Given a strong relevance of CPUs alongside AI accelerators, an ever-expanding AI infrastructure demand offers growth opportunities to Intel. But the company remains exposed to a stiffly competitive landscape, and will need to enhance its customer adoption, manufacturing execution, and profitability.
READ NEXT: 12 Best Industrial Stocks With More Than 50% Upside and 10 Best Stocks Under $10 That Could Triple.
